Insulin glargine and lixisenatide and Pharmorubicin Pfs
Determining the interaction of Insulin glargine and lixisenatide and Pharmorubicin Pfs and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
Generic Name: epirubicin
Brand name: Ellence, Pharmorubicin Pfs, Pharmorubicin RDF
Synonyms: Pharmorubicin Pfs (Intravenous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide-Phazyme
- Insulin glargine and lixisenatide-Phazyme Liquid Gas Relief, Maximum Strength
- Insulin glargine and lixisenatide-Phena-Plus
- Insulin glargine and lixisenatide-Phena-S
- Insulin glargine and lixisenatide-Phenadoz
- Insulin glargine and lixisenatide-Phenadoz rectal
- Pharmorubicin Pfs-Insulin glargine and lixisenatide Subcutaneous
- Pharmorubicin Pfs-Insulin glargine, recombinant Subcutaneous
- Pharmorubicin Pfs-Insulin glulisine
- Pharmorubicin Pfs-Insulin Glulisine (Cartridges and Pens)
- Pharmorubicin Pfs-Insulin Glulisine (Vials)
- Pharmorubicin Pfs-Insulin glulisine Subcutaneous